LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveDaiichi Sankyo Says Enhertu Approved in EU

Live News REGULATION FLASH M impact Oct 27, 2026, 07:53 AM UTC

Daiichi Sankyo Says Enhertu Approved in EU

Daiichi Sankyo said Enhertu has been approved in the EU.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Novo Nordisk Reportedly Loses US Ruling to Block Eli Lilly Drug Ads Novo Nordisk failed to convince a U.S. judge to block Eli Lilly weight-loss drug ads. L impact | REGULATION | Oct 27, 2026, 08:53 AM UTC Samsung Fined Over Galaxy Performance Limits Samsung was fined over omissions related to Galaxy performance limits. M impact | REGULATION | Oct 27, 2026, 08:43 AM UTC Privacy group files five complaints against Scale AI European digital privacy group noyb filed five complaints against Scale AI in France, Italy, the Netherlands and Austria over alleged employee monitoring. L impact | REGULATION | Oct 27, 2026, 08:41 AM UTC EU Weighs Restrictions on Chinese Chemical and Machinery Imports The headline reports EU restrictions on imports of Chinese chemicals and machinery but does not establish whether they have been proposed or adopted. L impact | REGULATION | Oct 27, 2026, 08:32 AM UTC Alibaba Wins Court Ruling Blocking Pentagon Restriction Alibaba shares fell 1.3% in early premarket trading Tuesday despite winning a court ruling Monday blocking the administration’s move to bar certain entities from doing business wit M impact | REGULATION | Oct 27, 2026, 08:31 AM UTC EU Approves AstraZeneca’s Enhertu for Early HER2-Positive Breast Cancer The European Commission approved Enhertu as an adjuvant monotherapy for HER2-positive early breast cancer. M impact | REGULATION | Oct 27, 2026, 08:31 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.